The Antibody Society

the official website of the antibody society

An international non-profit supporting antibody-related research and development.

  • LOG IN
  • BECOME A MEMBER
  • About
    • Mission & Activities
    • Directors and Officers
    • The Antibody Society’s Committees
      • Communication & Membership Committee
      • Meetings Committee
      • AIRR Community Working Groups & Subcommittees
    • Sponsors & Partners
  • Society meetings
    • Computational Antibody Discovery: State of the Art
      • Computational Antibody Discovery Symposium Participants
    • Harnessing Cytokines for Cancer Immunotherapy Symposium
    • Biopharmaceutical Informatics Symposium
    • Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells Symposium
    • Emerging Immunotherapeutics for Ovarian Cancer Symposium
    • AIRR Community Meetings
    • Antibody Engineering & Therapeutics (US) 2024
      • 2022 Antibody Engineering & Therapeutics
      • 2020 Antibody Engineering & Therapeutics
      • 2019 Antibody Engineering & Therapeutics
      • 2018 Antibody Engineering & Therapeutics
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics Europe 2024
      • Scientific Advisors, Antibody Engineering & Therapeutics Europe
    • FOCIS Symposia
  • AIRR Community
    • AIRR News
    • AIRR Community Seminar Series
    • AIRR Publications
    • AIRR Meetings
      • AIRR Community Meeting VII – Learnings and Perspectives
      • AIRR Community Special Event 2023  – Zooming in to the Community II
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-Committees
      • Communications Sub-Committee
      • Executive Sub-Committee
      • Inferred Allele Review Committee
      • Meetings Sub-Committee
      • Strategic Planning Sub-Committee
    • AIRR Data Commons
    • AIRR Community Calendar
    • AIRR Community Webinar Series
    • On AIRR – An AIRR Community Podcast
    • AIRR Community Resources
    • AIRR Community Service Prize
  • Members only
    • Login
    • Note to members
    • Member discount codes
    • 2024 Calendar of Events
    • James S. Huston Antibody Science Talent Award
      • 2022 James S. Huston Antibody Science Talent Award Recipient
      • 2021 James S. Huston Antibody Science Talent Award Recipient
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • Huston Award Criteria
    • Research Competitions
      • Research Competition Winners
    • Science Writing Competition
      • Science Writing Competition Winners
    • Imaging Competition
      • Imaging Calendar Competition winners
        • The Antibody Society 2024 Calendar
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars
    • Snakebite antivenoms: Global challenges and progress toward recombinant antibody therapeutics
    • Adaptive Immune Receptor Repertoires
    • Antibody Discovery & Development
    • Commercializing Antibody Therapeutics
    • Antibodies to Watch
    • Antibody Validation
      • 4th International Antibody Validation Meeting, Sep 2023
You are here: Home / About / Directors and Officers

Directors and Officers


The Antibody Society’s Board of Directors is a governing body with a fiduciary duty to further the best interests of the Society, and to oversee the conduct of the Society activities, supervise Officers and Committees, and set the standards of conduct and performance for the Society. Our directors, shown below:

  • Represent the Society to the community
  • Attract volunteers
  • Engage corporate sponsors
  • Participate with strategic planning and budgeting
  • Ensure smooth operation of the Society

Kerry A. Chester, Ph.D.

John Desjarlais, Ph.D.

Katherine Harris, Ph.D.

Mitchell Ho, Ph.D.*

Alex Lugovskoy, Ph.D.


Nina Luning Prak, M.D., Ph.D.
Paul ParrenPaul W.H.I. Parren, Ph.D.
Board Chair

Janice M. Reichert, Ph.D.

Janine Schuurman, Ph.D.

Eric Smith, Ph.D.


Sally Ward, Ph.D., FRS
 

*Dr. Mitchell Ho serves as a federal liaison.



The Antibody Society’s Officers manage the organization during the year and report to the Board of Directors.

The Society’s Officers are:

President (2024-25): : Janine Schuurman

Vice President (2024-25): Katherine Harris

Chief Operating Officer: Janice Reichert

Treasurer: Peter Thomson

Clerk: Ingrid Kingma




The Founding Board of Directors

The first annual meeting of The Antibody Society’s Board of Directors was held on December 2, 2007, following an organizational meeting held on May 22, 2007. The founding board members were:

Andrew Bradbury, M.B., B.S., Ph.D. Dennis R. Burton, Ph.D.

James S. Huston, Ph.D.

James Marks, Ph.D.
Andreas Plückthun, Ph.D.
Jamie Scott, M.D., Ph.D. Louis M. Weiner, M.D.  

James Huston served as the Founding President, Board Chair and the Treasurer of the organization. Michael K. Barron served as the Society’s first Clerk.

The Antibody Society thanks the founding board members for their outstanding dedication and service to the organization.

  • Home
  • Privacy & Terms of Use
  • About
  • Directors and Officers
  • Advisors
  • Sponsors & Partners
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals